AMERICAN CENTY ETF TR - US EQT ETF (AVUS)

CUSIP: 025072885

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / US EQT ETF
Total 13F shares
63,199,342
Share change
+2,628,832
Total reported value
$6,128,665,497
Put/Call ratio
10%
Price per share
$96.93
Number of holders
427
Value change
+$256,285,458
Number of buys
210
Number of sells
134

Security key

025072885

Report period

Q4 2024

Institutions

427

Top holders

10

Ownership snapshot

Top shareholders of AVUS - AMERICAN CENTY ETF TR - US EQT ETF (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
427
Shares
63,199,342
Rows loaded
429
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
376
Q4 2024 holders
427
Holder diff
51
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .